[go: up one dir, main page]

AU2003273474A8 - Less thanigreater thannless than/igreater than-(phenyl(piperidin-2-yl)methyl)benzamide derivatives, preparation thereof, and use thereof in therapy - Google Patents

Less thanigreater thannless than/igreater than-(phenyl(piperidin-2-yl)methyl)benzamide derivatives, preparation thereof, and use thereof in therapy

Info

Publication number
AU2003273474A8
AU2003273474A8 AU2003273474A AU2003273474A AU2003273474A8 AU 2003273474 A8 AU2003273474 A8 AU 2003273474A8 AU 2003273474 A AU2003273474 A AU 2003273474A AU 2003273474 A AU2003273474 A AU 2003273474A AU 2003273474 A8 AU2003273474 A8 AU 2003273474A8
Authority
AU
Australia
Prior art keywords
thannless
thanigreater
igreater
piperidin
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2003273474A
Other versions
AU2003273474A1 (en
Inventor
Mireille Sevrin
Gihad Dargazanli
Nathalie Rakotoarisoa
Pierre Roger
Benoit Marabout
Emmanuelle Dachary
Genevieve Estenne-Bouhtou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Publication of AU2003273474A8 publication Critical patent/AU2003273474A8/en
Publication of AU2003273474A1 publication Critical patent/AU2003273474A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003273474A 2002-07-29 2003-07-25 Less thanigreater thannless than/igreater than-(phenyl(piperidin-2-yl)methyl)benzamide derivatives, preparation thereof, and use thereof in therapy Abandoned AU2003273474A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR02/09589 2002-07-29
FR0209589A FR2842805A1 (en) 2002-07-29 2002-07-29 N- [PHENYL (PIPERIDIN-2-YL) METHYL] BENZAMIDE DERIVATIVES, THEIR PREPARATION AND APPLICATION THERAPEUTICS
PCT/FR2003/002355 WO2004013100A2 (en) 2002-07-29 2003-07-25 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy

Publications (2)

Publication Number Publication Date
AU2003273474A8 true AU2003273474A8 (en) 2004-02-23
AU2003273474A1 AU2003273474A1 (en) 2004-02-23

Family

ID=30011557

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273474A Abandoned AU2003273474A1 (en) 2002-07-29 2003-07-25 Less thanigreater thannless than/igreater than-(phenyl(piperidin-2-yl)methyl)benzamide derivatives, preparation thereof, and use thereof in therapy

Country Status (3)

Country Link
AU (1) AU2003273474A1 (en)
FR (1) FR2842805A1 (en)
WO (1) WO2004013100A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0408774D0 (en) * 2004-04-20 2004-05-26 Glaxo Group Ltd Compounds
EP1841418B1 (en) * 2005-01-14 2013-04-17 MSD Oss B.V. Glycine reuptake inhibitors for treating drug and alcohol dependence
WO2006134341A1 (en) * 2005-06-13 2006-12-21 Merck Sharp & Dohme Limited Therapeutic agents
CN101784533B (en) 2007-08-22 2013-08-21 艾博特股份有限两合公司 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy
ES2397764T3 (en) 2008-04-01 2013-03-11 Abbott Gmbh & Co. Kg Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
WO2010087761A1 (en) * 2009-01-28 2010-08-05 Astrazeneca Ab 2-aza-bicyclo[2.2.2]octane compounds and uses thereof
AR075442A1 (en) 2009-02-16 2011-03-30 Abbott Gmbh & Co Kg AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USES IN THERAPY
TW201038569A (en) 2009-02-16 2010-11-01 Abbott Gmbh & Co Kg Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
FR2943056A1 (en) * 2009-03-16 2010-09-17 Sanofi Aventis New N-(2-aza-bicyclo(2.2.1)-hex-1-yl)-aryl-methyl-heterobenzamide derivatives are glycine transporter 1 inhibitors useful to treat e.g. dementia, psychosis, schizophrenia, anxiety, panic attacks, and obsessive compulsive disorder
RU2011141778A (en) * 2009-03-16 2013-04-27 Санофи Derivatives of N - [(2-azabicyclo [2.1.1] HEX-1-IL) arylmethyl] heterobenzamide, their production and their use in therapy
US9051280B2 (en) 2010-08-13 2015-06-09 AbbVie Deutschland GmbH & Co. KG Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8883839B2 (en) 2010-08-13 2014-11-11 Abbott Laboratories Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en) 2010-08-13 2015-06-02 AbbVie Deutschland GmbH & Co. KG Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8877794B2 (en) 2010-08-13 2014-11-04 Abbott Laboratories Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8846743B2 (en) 2010-08-13 2014-09-30 Abbott Laboratories Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en) 2011-05-12 2016-04-12 AbbVie Deutschland GmbH & Co. KG Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
EP2723717A2 (en) 2011-06-24 2014-04-30 Amgen Inc. Trpm8 antagonists and their use in treatments
MX2013015058A (en) 2011-06-24 2014-01-20 Amgen Inc Trpm8 antagonists and their use in treatments.
US8853196B2 (en) 2011-08-05 2014-10-07 AbbVie Deutschland GmbH & Co. KG Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
CA2853254A1 (en) 2011-11-18 2013-05-23 Abbvie Inc. N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9365512B2 (en) 2012-02-13 2016-06-14 AbbVie Deutschland GmbH & Co. KG Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
US9650334B2 (en) 2013-03-15 2017-05-16 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9656955B2 (en) 2013-03-15 2017-05-23 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
CA2924699A1 (en) 2013-10-17 2015-04-23 AbbVie Deutschland GmbH & Co. KG Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
MX2016004936A (en) 2013-10-17 2016-12-20 Abbvie Deutschland Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquin oline derivatives, pharmaceutical compositions containing them, and their use in therapy.
US9550754B2 (en) 2014-09-11 2017-01-24 AbbVie Deutschland GmbH & Co. KG 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254569A (en) * 1991-01-14 1993-10-19 The Du Pont Merck Pharmaceutical Company (Amidomethyl)nitrogen heterocyclic analgesics
SK13092000A3 (en) * 1998-03-06 2001-03-12 Janssen Pharmaceutica N. V. Glycine transport inhibitors

Also Published As

Publication number Publication date
FR2842805A1 (en) 2004-01-30
WO2004013100A2 (en) 2004-02-12
WO2004013100A3 (en) 2004-04-15
AU2003273474A1 (en) 2004-02-23

Similar Documents

Publication Publication Date Title
AU2003273474A8 (en) Less thanigreater thannless than/igreater than-(phenyl(piperidin-2-yl)methyl)benzamide derivatives, preparation thereof, and use thereof in therapy
HRP20040977A2 (en) Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
IL174994A0 (en) Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
IL201409A0 (en) Cd40 antibody formulation and methods
IL180770A0 (en) Oxopiperidine derivatives, preparation and therapeutic use thereof
IL164463A0 (en) Use of osteoprotegerin in the preparation of medicaments
IL182624A0 (en) 2-amido-4 phenylthiazole derivatives, the preparation and the therapeutic use thereof
IL172316A0 (en) Novel compounds and their use in therapy
DK1590321T3 (en) Arylalkylcarbamate derivatives, preparation and therapeutic use thereof
IL180797A0 (en) Amino-tropane derivatives, preparation thereof and therapeutic use thereof
IL177047A0 (en) Oxazole derivatives, preparation and therapeutic use thereof
PT1525193E (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
EP1506956A4 (en) Diimonium salt mixtures, aminium salts mixtures and use thereof
PL376790A1 (en) 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof
PT1776340E (en) N-(1h-indolyl)-h-indole-2-carb0xamide derivatives, their preparation and their therapeutic use
GB2409069B (en) Administration of computing entities in a network
IL173188A0 (en) Use of alcohol-oxyalkyates in the form of adjuvants for benzamidoxime gungicidal derivatives, appropriate agents and kits
SI1828137T1 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
PL375309A1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
EP1900735A4 (en) Pyridazinyl amine derivatives, the use thereof in the preparation of picorna virus inhibitors
NO20045723D0 (en) Nitrogen-containing compound, preparation thereof and use in amino-aldehyde resins
TWI340642B (en) Acylaminothiazole derivatives, preparation and therapeutic application thereof
ZA200700603B (en) 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
ZA200704650B (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
GB0203042D0 (en) Anthraquinine compounds their preparation and their use in therapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase